L. F. Barker

875 total citations
27 papers, 662 citations indexed

About

L. F. Barker is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, L. F. Barker has authored 27 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 16 papers in Hepatology and 7 papers in Infectious Diseases. Recurrent topics in L. F. Barker's work include Hepatitis B Virus Studies (19 papers), Hepatitis C virus research (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). L. F. Barker is often cited by papers focused on Hepatitis B Virus Studies (19 papers), Hepatitis C virus research (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). L. F. Barker collaborates with scholars based in United States, Australia and Thailand. L. F. Barker's co-authors include Jay H. Hoofnagle, Jules L. Dienstag, Michael R. Peterson, Ruth L. Kirschstein, Robert J. Gerety, Dan W. Dalgard, D. G. Sharp, Thomas S. Edgington, Philip P. McGrath and June D. Almeida and has published in prestigious journals such as JAMA, Environmental Health Perspectives and The Journal of Infectious Diseases.

In The Last Decade

L. F. Barker

26 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. F. Barker United States	12	475	473	186	50	48	27	662
Bert L. Murphy United States	13	402 0.8×	375 0.8×	137 0.7×	11 0.2×	41 0.9×	19	538
Yoshiyuki Nakatsuji Japan	10	661 1.4×	650 1.4×	163 0.9×	22 0.4×	27 0.6×	25	852
M. Duhamel Belgium	6	532 1.1×	574 1.2×	102 0.5×	17 0.3×	31 0.6×	8	743
H. Ikram United States	9	371 0.8×	280 0.6×	103 0.6×	29 0.6×	64 1.3×	16	515
Karen Cristiano Italy	11	538 1.1×	580 1.2×	169 0.9×	23 0.5×	16 0.3×	22	780
J. Wai-Kuo Shih United States	8	400 0.8×	386 0.8×	80 0.4×	16 0.3×	42 0.9×	9	528
J. Wages United States	8	600 1.3×	518 1.1×	143 0.8×	21 0.4×	25 0.5×	8	738
Ulrike C. Wend Germany	17	980 2.1×	934 2.0×	171 0.9×	22 0.4×	45 0.9×	28	1.1k
Montserrat Cotrina Spain	13	600 1.3×	789 1.7×	294 1.6×	30 0.6×	17 0.4×	18	900
Joëlle Lerable France	9	316 0.7×	299 0.6×	164 0.9×	17 0.3×	28 0.6×	14	474

Countries citing papers authored by L. F. Barker

Since Specialization

Citations

This map shows the geographic impact of L. F. Barker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. F. Barker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. F. Barker more than expected).

Fields of papers citing papers by L. F. Barker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. F. Barker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. F. Barker. The network helps show where L. F. Barker may publish in the future.

Co-authorship network of co-authors of L. F. Barker

This figure shows the co-authorship network connecting the top 25 collaborators of L. F. Barker. A scholar is included among the top collaborators of L. F. Barker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. F. Barker. L. F. Barker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barker, L. F., et al.. (2025). Sports Supplement Analysis Survey for the Prevalence of WADA Prohibited Substances in the Australian Online Marketplace. Drug Testing and Analysis. 17(10). 1857–1864. 2 indexed citations

Barker, L. F., et al.. (2000). Development of a pollution prevention and energy efficiency clearinghouse for biomedical research facilities.. Environmental Health Perspectives. 108(suppl 6). 949–951. 1 indexed citations

Hoff, Rodney & L. F. Barker. (1995). Trial objectives and end points for measuring the efficacy of HIV vaccines.. PubMed. 4(2). 95–101. 8 indexed citations

Nath, N., et al.. (1982). Hepatitis‐Associated Markers in the American Red Cross Volunteer Blood Donor Population. Vox Sanguinis. 42(4). 203–210. 12 indexed citations

Aach, Richard D., Harrison Alter, L. F. Barker, et al.. (1981). Should Donors with a History of Jaundice Still be Rejected?. Vox Sanguinis. 41(2). 110–127. 2 indexed citations

Dodd, Roger Y., et al.. (1980). Hepatitis‐Associated Markers in the American Red Cross Volunteer Blood Donor Population. Vox Sanguinis. 39(6). 309–317. 3 indexed citations

Barker, L. F. & Robert J. Gerety. (1976). The clinical problem of hepatitis transmission;.. PubMed. 11. 163–82. 2 indexed citations

Dienstag, Jules L., et al.. (1976). Hepatitis A Antigen Particles in Liver, Bile, and Stool of Chimpanzees. The Journal of Infectious Diseases. 134(1). 80–84. 65 indexed citations

Hoofnagle, J H, et al.. (1975). Hepatitis A Antigen in Liver, Bile and Stool. Proceedings annual meeting Electron Microscopy Society of America. 33. 340–341. 1 indexed citations

10.

Markenson, Joseph A., R. J. Gerety, Jay H. Hoofnagle, & L. F. Barker. (1975). Effects of Cyclophosphamide on Hepatitis B Virus Infection and Challenge in Chimpanzees. The Journal of Infectious Diseases. 131(2). 79–87. 20 indexed citations

11.

Dienstag, Jules L., S M Feinstone, R H Purcell, et al.. (1975). Experimental Infection of Chimpanzees with Hepatitis A Virus. The Journal of Infectious Diseases. 132(5). 532–545. 118 indexed citations

12.

Cooksley, W. G. E., Lawrie W. Powell, Steven P. Mistilis, I. R. Mackay, & L. F. Barker. (1975). Hepatitis B antigen and antibody in active chronic hepatitis and other liver diseases in Australia. Digestive Diseases and Sciences. 20(2). 110–114. 8 indexed citations

13.

Hoofnagle, Jay H., Robert J. Gerety, & L. F. Barker. (1975). Hepatitis B core antigen and antibody.. PubMed. 30. 175–85. 8 indexed citations

14.

Barker, L. F.. (1973). Antibody responses in viral hepatitis, type B. JAMA. 223(9). 1005–1008. 22 indexed citations

15.

Barker, L. F., Francis V. Chisari, Philip P. McGrath, et al.. (1973). Transmission of Type B Viral Hepatitis to Chimpanzees. The Journal of Infectious Diseases. 127(6). 648–662. 168 indexed citations

16.

Peterson, Michael R., et al.. (1973). Detection of Antibody to Hepatitis‐Associated Antigen in Hemophilia Patients and in Voluntary Blood Donors. Vox Sanguinis. 24(1). 66–75. 59 indexed citations

17.

Barker, L. F., et al.. (1973). Vaccinia virus strain differences. Archives of Virology. 42(2). 117–124. 3 indexed citations

18.

Barker, L. F. & Michael R. Peterson. (1972). Detection of hepatitis associated antigen and antibody--comparison of methods and their application.. PubMed. 106. Suppl:486–92. 5 indexed citations

19.

Morrow, Richard H., et al.. (1971). Australia Antigen and Hepatitis in Accra, Ghana. BMJ. 4(5784). 389–391. 13 indexed citations

20.

Stevens, David, et al.. (1969). Lymphoblastoid Cell Cultures from Patients with Infectious Hepatitis. Experimental Biology and Medicine. 132(3). 1042–1045. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact